Page results
-
The lymphoedema service at UCLH provides assessment, diagnosis, treatment and management of cancer-related lymphoedema.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
The heart failure service provides comprehensive care for patients with heart failure.
-
The rapid access chest pain clinic provides a quick and early specialist cardiology assessment for patients who need urgent assessment.
-
We provide a wide range of general paediatric services, led by a team of enthusiastic consultants and dedicated nurses.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
-
We provide effective, evidence-based nutritional assessment, dietary advice, nutritional intervention and support to patients, their carers and all staff involved in patient care. The main aim of this advice is the prevention or correction of nutrition-related symptoms and/or disease.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
File results
-
FOI/2024/0475 - Prophylactic hydrocortisone neonatal deaths in 2023
-
FOI/2024/0091 - Primary HIFU PA procedures/ salvage HIFU procedures HEAT registry
-
FOI/2024/0548 - Patient transport services, providers/ charges
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0560 - Coroners' Prevention of Future Deaths Reports
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0564 - Transperineal prostate biopsies undertaken in 2023
-
FOI/2024/0568 - Local Anaesthetic Transperineal Prostate (LATP) biopsy service
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND